- CNBC•19 hours ago
Jim Cramer rattled off his take on caller favorite stocks, including defense contractor Raytheon.
- Motley Fool•22 hours ago
AstraZeneca, Bristol-Myers Squibb, and Pfizer receive good news from the real world.
Pfizer, Inc.'s (PFE) rheumatoid arthritis (RA) drug, Xeljanz has received marketing approval in Europe.
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||34.11 - 34.45|
|52 Week Range||29.41 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.35|
|Dividend & Yield||1.28 (3.74%)|
|1y Target Est||N/A|